- Home
- CRBU vs DAVA Comparison
CRBU vs DAVA Comparison
Compare CRBU & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRBU | DAVA |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.8M | 159.1M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CRBU | DAVA |
|---|---|---|
| Price | $1.57 | $3.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $10.75 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 917.9K | 173.4K |
| Earning Date | 05-08-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.63 | N/A |
| Revenue Next Year | $10.93 | $4.07 |
| P/E Ratio | ★ N/A | $20.02 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.38 | $2.55 |
| 52 Week High | $3.53 | $10.29 |
Technical Indicators
Market Signals| Indicator | CRBU | DAVA |
|---|---|---|
| Relative Strength Index (RSI) | 43.49 | 51.22 |
| Support Level | $1.52 | $2.64 |
| Resistance Level | $1.72 | $3.22 |
| Average True Range (ATR) | 0.08 | 0.14 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 10.64 | 37.50 |
Price Performance
Historical ComparisonAbout CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.